Results 281 to 290 of about 983,670 (345)
Abstract Aims Inflammation plays a critical role in both the development and progression of heart failure (HF), which is a leading cause of morbidity and mortality worldwide. However, the causality between specific inflammation‐related proteins and HF risk remains unclear.
Xian‐Guan Zhu +9 more
wiley +1 more source
Determination of Induction Time in Adult Patients with Valvular Heart Disease. [PDF]
Mital T +4 more
europepmc +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 1514-1522, April 2025.
Takamasa Iwai +4 more
wiley +1 more source
Assessing the prevalence of extensive macular atrophy with pseudodrusen-like appearance in patients with rheumatic fever-associated valvular heart disease: a cross-sectional study. [PDF]
Cassavia Junior ASF +8 more
europepmc +1 more source
Abstract Aims SPARCL1 was recently identified as a biomarker of right ventricular (RV) maladaptation in patients with pulmonary hypertension (PH), and N‐terminal pro‐brain natriuretic protein (NT‐proBNP) is an established biomarker of RV failure in PH. The present study investigated whether NT‐proBNP and SPARCL1 concentrations are associated with load ...
Oliver Dörr +15 more
wiley +1 more source
Valvular Heart Disease: Geography Is Destiny! [PDF]
Bakaeen FG, Jaber W, Kaur S.
europepmc +1 more source
This study analyzes 148 patients (66 women and 82 men) with chronic myeloid leukemia treated with tyrosine kinase inhibitors, focusing on cardiovascular adverse events. The risk assessment, performed using the HFA/ICOS score, reveals sex‐specific differences: venous thrombosis is more common in women, while arterial thrombosis predominates in men.
Cristina Madaudo +10 more
wiley +1 more source
Health and Labor Force Participation over the Life Cycle: Evidence from the Past [PDF]
Peter Viechnicki
core
The Valvular Heart Disease in Women (VHD-W) Registry: a global initiative to address gender disparities in management and outcomes. [PDF]
Anwer S +10 more
europepmc +1 more source
The role of the bone morphogenetic protein receptor 2 pathway in group 2 pulmonary hypertension secondary to valvular heart disease. [PDF]
Martínez-Solano J +14 more
europepmc +1 more source

